Background Besides being a causative agent for genital warts and cervical cancer, human
papillomavirus (HPV) contributes to 40-85% of cases of anal, penile, vaginal and vulvar …

Objective: To assess the health and economic burden of human papillomavirus (HPV)-
related diseases (cervical cancer, cervical intraepithelial neoplasia (CIN) 1/2/3, and genital …

Background The role of human papillomavirus (HPV) in malignant and non-malignant
genital diseases in women is well known and the corresponding epidemiological burden …

Purpose A complete economic evaluation requires accurate data concerning the resources
used, outcomes, and utilities (patient's preferences) to properly value the cost utility of …

OBJECTIVE: The purpose of this study was (1) to estimate the direct medical costs of 7 major
noncervical human papillomavirus (HPV)–related conditions that include genital cancers …

The prevalence of genital warts (GW) and self-reported human papillomavirus (HPV) as well
as disease-related psychosocial impact among male and female patients aged 18–60 years …

Abstract Background Anogenital warts (AGWs) are a common, highly infectious disease
caused by the human papillomavirus (HPV), whose high recurrence rates contribute to direct …

Objectives To assess the association between smoking and the reported clinical diagnosis
of genital warts. Methods A sample of 58 094 women (aged 18–45) randomly drawn from …

Objective The quadrivalent human papillomavirus (HPV) vaccine is effective against HPV
types responsible for 90% of anogenital warts. This study estimated the quality of life lost to …

Methods We adapted an existing mathematical model of HPV transmission and associated
diseases to estimate the lifetime number of diagnosed cases of disease (genital warts; …